Aiming to establish biomarkers for bladder cancers, research led by Celis [106] and Ostergaard [107] reported increased levels of Psoriasin (also known as S100A7) in squamous cell carcinomas (SCCs) and urine samples from cancer patients. Here, S100A7 is linked to urinary bladder cancer.